ORPH

Open Orphan Plc

Open Orphan’s new quarantine clinic in London

Dublin-listed Open Orphan has opened a new quarantine clinic in London. The new site is based in Whitechapel, directly opposite the Queen Mary BioEnterprise Innovation Centre (QMB) which is home

Open Orphan Plc

What is a Human Challenge Study?

During a human challenge study, a small number of healthy volunteers will receive a vaccine or drug which will be used to fight viruses. Volunteers are quarantined in our bespoke

Open Orphan Plc

Open Orphan further contract renewal with Carna Biosciences

Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces a further contract

Open Orphan Plc

Drug Discovery Today: Modelling the world

With the global prevalence of novel, emergent and largely zoonotic pathogens achieving new historical heights, it is imperative that researchers in the field of infectious disease find ways of modelling

Open Orphan Plc

Open Orphan article published in Drug Discovery Today

Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organization (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, has announced an